Search research articles
Contact Us
Filters
Showing results (1-10 of 294) with videos related to
Page
of 30
Sort By:
Transplantation and Cellular Therapy
|
August 28, 2025
Profile of a Pioneer: Rainer F. Storb
Brenda M Sandmaier
Expert Review of Hematology
|
April 13, 2010
Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasms
Aravind Ramakrishnan, Brenda M Sandmaier
Haematologica
|
May 2, 2016
Nonmyeloablative allogeneic hematopoietic cell transplantation
Rainer Storb, Brenda M Sandmaier
Transplantation and Cellular Therapy
|
October 9, 2025
Salvage Allogeneic Hematopoietic Cell Transplantation for Primary Graft Failure
Boglarka Gyurkocza, Brenda M Sandmaier
Current Opinion in Hematology
|
October 12, 2005
Current status of hematopoietic stem cell transplantation after nonmyeloablative conditioning
Frédéric Baron, Brenda M Sandmaier
Hematology. American Society of Hematology. Education Program
|
December 5, 2025
New age HCT conditioning regimens: what works and why?
Naveed Ali, Brenda M Sandmaier
Blood
|
June 11, 2014
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
Boglarka Gyurkocza, Brenda M Sandmaier
Blood
|
August 13, 2010
Who is fit for allogeneic transplantation?
H Joachim Deeg, Brenda M Sandmaier
Seminars in Oncology
|
February 19, 2004
Targeted cancer therapy and immunosuppression using radiolabeled monoclonal antibodies
Wolfgang A Bethge, Brenda M Sandmaier
Expert Review of Vaccines
|
December 21, 2004
Vaccination with Theratope (STn-KLH) as treatment for breast cancer
Leona A Holmberg, Brenda M Sandmaier
Page
of 30
Search research articles
Search
Showing results (1-10 of 294) with videos related to
Sort By:
Page
of 30
Transplantation and Cellular Therapy
|
August 28, 2025
Profile of a Pioneer: Rainer F. Storb
Brenda M Sandmaier
Expert Review of Hematology
|
April 13, 2010
Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasms
Aravind Ramakrishnan, Brenda M Sandmaier
Haematologica
|
May 2, 2016
Nonmyeloablative allogeneic hematopoietic cell transplantation
Rainer Storb, Brenda M Sandmaier
Transplantation and Cellular Therapy
|
October 9, 2025
Salvage Allogeneic Hematopoietic Cell Transplantation for Primary Graft Failure
Boglarka Gyurkocza, Brenda M Sandmaier
Current Opinion in Hematology
|
October 12, 2005
Current status of hematopoietic stem cell transplantation after nonmyeloablative conditioning
Frédéric Baron, Brenda M Sandmaier
Hematology. American Society of Hematology. Education Program
|
December 5, 2025
New age HCT conditioning regimens: what works and why?
Naveed Ali, Brenda M Sandmaier
Blood
|
June 11, 2014
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
Boglarka Gyurkocza, Brenda M Sandmaier
Blood
|
August 13, 2010
Who is fit for allogeneic transplantation?
H Joachim Deeg, Brenda M Sandmaier
Seminars in Oncology
|
February 19, 2004
Targeted cancer therapy and immunosuppression using radiolabeled monoclonal antibodies
Wolfgang A Bethge, Brenda M Sandmaier
Expert Review of Vaccines
|
December 21, 2004
Vaccination with Theratope (STn-KLH) as treatment for breast cancer
Leona A Holmberg, Brenda M Sandmaier
Page
of 30